Adomeglivant

DB11704InvestigationalSmall molecule

Adomeglivant has been investigated for the basic science of Type 2 Diabetes.

Chemical structure of Adomeglivant
Mechanism
Curator reviewed
Formula / weight
C32H36F3NO4 · 555.638 g/mol (avg)
Code names
LY-2409021

Resolves to

Compound
UNII74Z5ZL2KVGCAS1488363-78-5ChEMBLCHEMBL3707351PubChem91933867
Structure
InChIKeyFASLTMSUPQDLIB-MHZLTWQESA-NSMILESCC1=CC(O[C@@H](CCC(F)(F)F)C2=CC=C(C=C2)C(=O)NCCC(O)=O)=CC(C)=C1C1=CC=C(C=C1)C(C)(C)C
Targets
P47871GCGR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Adomeglivant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In